According to an NBC News article, an FDA panel rejected Biogen’s experimental Alzheimer’s drug due to a lack of “strong evidence” it works. The drug is aducanumab, and it has received ample criticism after experts identified “red flags” in the data, which didn’t show any initial benefits.
FDA Panel Rejects New Alzheimer’s Drug
Biogen’s experimental Alzheimer’s drug lacks enough evidence for FDA approval.
Nov 11, 2020
Start 2026 with Smarter Packaging for Life Sciences at PACK EXPO East!
Be the first to find what’s next in packaging for life sciences at PACK EXPO East. See solutions from 500 exhibitors, gain inspiration in free educational sessions and uncover new ideas for your industry and beyond—all in one trip to Philadelphia.
REGISTER NOW & SAVE
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Downloads
